Wharton’s Jelly-Derived Mesenchymal Stem Cells Reduce Fibrosis in a Mouse Model of Duchenne Muscular Dystrophy by Upregulating microRNA 499
The aim of this study was to evaluate the therapeutic effects and mechanisms of Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) in an animal model of Duchenne muscular dystrophy (DMD). Mdx mice (3–5 months old) were administered five different doses of WJ-MSCs through their tail veins. A we...
Main Authors: | Sang Eon Park, Jang Bin Jeong, Shin Ji Oh, Sun Jeong Kim, Hyeongseop Kim, Alee Choi, Suk-joo Choi, Soo-young Oh, Gyu Ha Ryu, Jeehun Lee, Hong Bae Jeon, Jong Wook Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/9/1089 |
Similar Items
-
Anti-Fibrotic Effect of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells on Skeletal Muscle Cells, Mediated by Secretion of MMP-1
by: Alee Choi, et al.
Published: (2020-08-01) -
Wharton’s jelly absence: a possible cause of stillbirth
by: Eduarda Bittencourt Damasceno, et al.
Published: (2013-12-01) -
Pressure Stimuli Improve the Proliferation of Wharton’s Jelly-Derived Mesenchymal Stem Cells under Hypoxic Culture Conditions
by: Sang Eon Park, et al.
Published: (2020-09-01) -
Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
by: Min-Soo Seo, et al.
Published: (2021-02-01) -
Positive correlation between the quantity of Wharton’s jelly in the umbilical cord and birth weight
by: Avsar A. Filiz, et al.
Published: (2011-03-01)